Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




November 16th CEOcast Weekly Newsletter

QualityStocks (November 16th, 2009) Writes:

Companies featured in this edition of the newsletter: ACTC, CVM, CHIP, ENZ, HYTM, IWEB, ONEZ, PHC, SIHI, SRCO

Markets continued their strong performance this week in the absence of any major market driving earnings or economic reports, as the broad based buying that characterized the previous week continued and led to gains in all of the major indices. All told, the Dow added 2.5% on the week, gaining 247 points to close at 10,270, up 17.0% on the year. The Nasdaq posted a 2.6% gain on the week, closing at 2,167 to extend its yearly gains to 37.5%, while the S&P 500 and Russell 2000 gained 2.3% and 1.0% respectively, bringing their yearly gains to 21.1% and 17.4%.

Equity markets carried the momentum from the previous week’s session, as the thin economic calendar and lack of significant earnings reports provided little incentive for investors to slow their buying activities.

...
Tags for this Post:
Advanced Cell Technologies, Arthritis, Bank of America Merrill Lynch;, BJ’s Wholesale, Canada, Capstone facility, CEL-SCI Corporation, cell therapy, cent;, chief scientific officer, China, Citigroup, Cleveland Clinic, cloud storage networks, credit monitoring, Crystal City, Dell, Detroit, Deutsche Bank, Dow Jones, electronics supply chain management, energy, Enzo Biochem, Fda, Ford Motor Company, fresh bamboo health products, green process manufacturer, H1N1, H1N1 virus;, health and security identification tools, Health Solutions, healthcare, healthcare services revenues, herpes simplex, HIV, Home-Depot, Hythiam, Iceweb, immunization, Infectious Diseases, Influenza, Investing Lessons, Japan, Kenneth S. Rosenthal, Kobe, Korea, Las Vegas, Lazard, LEAPS vaccine, LEAPS vaccine technology, Lowe’s, Modular Lightweight Portable (MLP), Modular Lightweight Portable (MLP) server, Morgan Stanley, New York, Northeastern Ohio Universities College of Medicine, ONE Holdings, Oppenheimer & Co., Optimus Capital Partners, organic food product line, outpatient behavioral health services, philadelphia fed, Pioneer Behavioral Health, PositiveID Corp, Professor of Immunology, Professor of Immunology and Microbiology, radio frequency identification systems, RECEPTORS LLC;, reporting, Rheumatoid Arthritis, Robert Lanza, San Francisco, Sears Holdings, Seoul, Seven Hills Behavioral Institute, Sidoti & Co., SinoHub, Small & Micro Cap, Sparta Commercial Services, Steel Vault, Stem Cells, supermarket operators, target, treatment of infectious diseases, United Green Technology Inc., USD, vaccine technology, Vaccines, vegetable products, VeriChip Corporation, Virginia

NVAX, PWRM, DrStockPick.com Stock Report! Novavax Inc. and Power 3 Medical Products Inc.

Dr. Stock Pick (November 16th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday November 16, 2009

DrStockPick.com Stock Report!

NVAX, PWRM

**************************************************************

NVAX, Novavax Inc.

NVAX is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India.

NVAX announced today that enrollment has been completed in the first stage of a two-stage

...
Tags for this Post:
advertisement services, ALS, Avimex Laboratories, Beijing, Biotechnology, Breast Cancer, broker, Cadila Pharmaceuticals, cancer, Chair and Keynote Speaker, chief scientific officer, China, Congress, country-specific vaccine solutions, Crown Equity Holdings Inc.;, diagnostic tests, Dr Stock Pick, equity trader, Fda, H1N1, H1N1 virus;, Houston, India, Infectious Diseases, Influenza, International Congress, Investing Lessons, Ira Goldknopf, Mexico, Mexico City, neurodegenerative disease;, Novavax Inc., NVAX, pandemic influenza, Power 3 Medical Products Inc., president, professional investment analyst and consultant, PWRM, stock featured on our site;, Stock Pick, Stocks to Watch, Texas, USD, Vaccines, VLP, VLP technology, www.BestOTC.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.novavax.com, www.PennyOmega.com, www.power3medical.com, www.stock-ir.com, www.stock-pr.com

Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca – Press Releases

Zacks Market Commentaries (November 16th, 2009) Writes:

For Immediate Release

Chicago, IL – November 16, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: GlaxoSmithKline plc (GSK), Sanofi-Aventis (SNY), Novartis (NVS), Baxter International (BAX) and AstraZeneca (AZN).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Friday’s Analyst Blog:

Glaxo H1N1 Vaccine Approved

GlaxoSmithKline plc (GSK) recently received approval from the U.S. Food and Drug Administration (FDA) for its unadjuvanted influenza A (H1N1) pandemic vaccine. The FDA approved the supplemental biologics license application (sBLA), which was filed as a strain change supplement to Glaxo’s FluLaval seasonal flu vaccine. This

...

Glaxo H1N1 Vaccine Approved – Analyst Blog

Zacks Market Commentaries (November 13th, 2009) Writes:
GlaxoSmithKline plc (GSK) recently received approval from the U.S. Food and Drug Administration (FDA) for its unadjuvanted influenza A (H1N1) pandemic vaccine.  The FDA approved the supplemental biologics license application (sBLA), which was filed as a strain change supplement to Glaxo’s FluLaval seasonal flu vaccine. This means that Glaxo can now market its swine flu vaccine for use in adults to prevent influenza.     The company has already received an order for 7.6 million doses of its swine flu vaccine from the United States Department of Health and Human Services. This order is a part of the US Government’s intention to secure about 250 million doses to help fight the swine flu pandemic.   The current outbreak of swine flu pandemic can prove to be a big opportunity for vaccine manufacturers. In addition to Glaxo, other major players in this field include Sanofi-Aventis (SNY), Novartis ...

Glaxo Reports Higher Revenues – Analyst Blog

Zacks Market Commentaries (November 12th, 2009) Writes:
GlaxoSmithKline, plc (GSK) reported third quarter income of 92 cents per American Depository Share (ADS), 3 cents below the Zacks Consensus Estimate. The company reported earnings of 94 cents in the year-ago period. Third quarter 2009 revenue increased 3%, with growth being driven by strong performances in emerging markets (up 25%), Japan (up 19%) and Consumer Healthcare (up 8%). We were pleased to see growth in Consumer Healthcare revenue despite the global slowdown. Meanwhile, US sales continued to be impacted by generic competition with revenue declining 12%. Sales of products like Imigran (down 74%), Lamictal (down 21%) and Requip (down 30%) and Wellbutrin XL (down 81%) kept declining. Pharmaceutical product revenue increased 2% with sales being driven by Advair/Seretide (up 5%) and Relenza. Relenza benefited from continued orders from several governments for stockpiling. Although vaccine sales were lower in the third quarter due ...

AQNM, Aquentium Air Purification Systems Designed to Be Used as a Prevention Against Influenza

Dr. Stock Pick (November 2nd, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

Monday November 2, 2009

DrStockPick.com Stock Report!

**************************************************************

Aquentium Air Purification Systems Designed to Be Used as a Prevention Against Influenza

North Palm Springs, CA - (WORLD STOCK WIRE) - November 2, 2009 — Aquentium, Inc. (OTCBB:AQNM) announced today that their ozone air purification equipment is as an environmentally friendly technology that can be used as a prevention against influenza. Ozone is the second most powerful sterilant in the world and its function is to destroy bacteria, viruses and odors.

WHAT IS OZONE?

Ozone is a molecule composed of three atoms of oxygen.

...

Difficult Year for Mexican Airlines – Analyst Blog

Zacks Market Commentaries (October 27th, 2009) Writes:
Grupo Aeroportuario del Sureste, S.A.B. de C.V. (ASR) announced results for the three-month periods ended September 30, 2009. For the third quarter of 2009, total passenger traffic declined year-over-year by 13.86%. International passenger traffic declined 19.01% while domestic passenger traffic declined by 8.36%. On April 28, 2009 the World Health Organization announced the outbreak of the H1N1 Influenza in Mexico . As a result, total year-over-year passenger traffic declined 2.1% in April, 50.7% in May, 28.4% in June, 16.7% in July, 12.8% in August and 10.7% in September. The 19.01% decline in international passenger traffic resulted mainly from a decline of 20.23% in international traffic at the Cancun airport. The 8.36% decline in domestic passenger traffic resulted mainly from declines of 13.94%, 11.33%, 18.12%, 32.50% and 38.06% at the Merida , Veracruz , Villahermosa , Cozumel and Tapachula airports, respectively. Net income declined 27.01% to ...

PWRM, BCRX, DrStockPick.com Stock Report! Power 3 Medical Products Inc. and BioCryst Pharmaceuticals, Inc.

Dr. Stock Pick (October 26th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday October 26, 2009

DrStockPick.com Stock Report!

PWRM, BCRX

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

Power3 Medical Products, Inc. is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). Power3 expects to complete phase II clinical

...
Tags for this Post:
advertisement services, ALS, Barack Obama, Beijing, BioCryst Pharmaceuticals Inc;, Breast Cancer, broker, cancer, Chair and Keynote Speaker, chief scientific officer, China, Congress, Crown Equity Holdings Inc.;, cutaneous T-cell lymphoma, diagnostic tests, Dr Stock Pick, equity trader, Fda, H1N1, Houston, Infectious Diseases, Influenza, International Congress, Investing Lessons, Ira Goldknopf, neurodegenerative disease;, Pharmaceuticals, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, president, professional investment analyst and consultant, stock featured on our site;, Stock Pick, Stocks to Watch, Swine Flu;, Texas, U.S. Centers for Disease Control and Prevention, U.S. Food and Drug Administration, United States, White House, www.biocryst.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com

BCRX, AEMD, CVAT, DrStockPick.com Watch List! for Monday October 26, 2009, BioCryst Pharmaceuticals, Inc., Aethlon Medical Inc. and Cavitation Technologies Inc.

Dr. Stock Pick (October 25th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

DrStockPick.com Watch List!

My Picks for Monday October 26, 2009, are:

**************************************************************

BCRX, BioCryst Pharmaceuticals, Inc.

U.S. President Barack Obama has declared 2009 H1N1 swine flu a national emergency, the White House said on Saturday.

BCRX designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases. BCRX has progressed two novel compounds into late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA), in response to a request from the U.S. Centers for Disease Control and Prevention,

...
Tags for this Post:
advertisement services, advertising services, Aethlon Medical Inc.;, Barack Obama, beverage, BioCryst Pharmaceuticals Inc;, broker, cancer, Cavitation Process Systems, Cavitation Technologies Inc., chemical industries, Crown Equity Holdings Inc.;, cutaneous T-cell lymphoma, CVAT, diagnostic and therapeutic device solutions, Dr Stock Pick, equity trader, Far East, food, H1N1, H1N1 virus;, Infectious Disease, Infectious Diseases, Influenza, Investing Lessons, Japan, leader in the development, Miura Engineering Co. Ltd., Nano Cavitation Technologies, Pharmaceuticals, president, professional investment analyst and consultant, stock featured on our site;, Stock Pick, Stocks to Watch, strain, Swine Flu;, Tokyo, U.S. Centers for Disease Control and Prevention, U.S. Food and Drug Administration, United States Department of Health and Human Services, United States, vegetable oil refining, White House, www.aethlonmedical.com, www.biocryst.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.miura21.co.jp, www.stock-ir.com

President Barack Obama Declares Swine Flu a National Emergency. Emergency Use Authorization Granted For BCRX’s Peramivir. BCRX, X-Treme Hot Stock Alert by DrStockPick.com

Dr. Stock Pick (October 24th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

Saturday October 24, 2009

DrStockPick.com Stock Report!

**************************************************************

U.S. President Barack Obama has declared 2009 H1N1 swine flu a national emergency, the White House said on Saturday.

________________________________________________

BCRX, BioCryst Pharmaceuticals, Inc.

BCRX designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases.  BCRX has progressed

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.